Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

D. Selleslag · SciRah

Researcher profile · Semantic Scholar

D. Selleslag

Share profile

D. Selleslag — researcher profile on SciRah

h-index: 46
Works: 276
Citations: 13K

Most-cited papers

Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial.
J. Maertens, I. Raad, K. Marr, T. Patterson +24 more
2016The Lancet873 citations
Semantic Scholar
Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes.
P. Fenaux, U. Platzbecker, G. Mufti, G. Garcia-Manero +39 more
2020New England Journal of Medicine462 citations Open access
Semantic Scholar
Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission.
A. Wei, H. Döhner, C. Pocock, P. Montesinos +25 more
2020New England Journal of Medicine347 citations Open access
Semantic Scholar
A dominant gain-of-function mutation in universal tyrosine kinase SRC causes thrombocytopenia, myelofibrosis, bleeding, and bone pathologies
E. Turro, D. Greene, Anouck Wijgaerts, C. Thys +39 more
2016Science Translational Medicine130 citations Open access
Semantic Scholar
Randomized phase 2 trial of pevonedistat plus azacitidine versus azacitidine for higher-risk MDS/CMML or low-blast AML
M. Sekeres, J. Watts, A. Radinoff, M. A. Sangerman +14 more
2021Leukemia97 citations Open access
Semantic Scholar
The QUAZAR AML-001 Maintenance Trial: Results of a Phase III International, Randomized, Double-Blind, Placebo-Controlled Study of CC-486 (Oral Formulation of Azacitidine) in Patients with Acute Myeloid Leukemia (AML) in First Remission
A. Wei, H. Döhner, C. Pocock, P. Montesinos +25 more
201997 citations Open access
Semantic Scholar
Eltrombopag for advanced myelodysplastic syndromes or acute myeloid leukaemia and severe thrombocytopenia (ASPIRE): a randomised, placebo-controlled, phase 2 trial.
M. Mittelman, U. Platzbecker, B. Afanasyev, S. Grosicki +10 more
2018The Lancet Haematology90 citations
Semantic Scholar
Azacitidine improves clinical outcomes in older patients with acute myeloid leukaemia with myelodysplasia-related changes compared with conventional care regimens
J. Seymour, H. Döhner, A. Butrym, A. Wierzbowska +17 more
2017BMC Cancer67 citations Open access
Semantic Scholar
The Medalist Trial: Results of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Luspatercept to Treat Anemia in Patients with Very Low-, Low-, or Intermediate-Risk Myelodysplastic Syndromes (MDS) with Ring Sideroblasts (RS) Who Require Red Blood Cell (RBC) Transfusions
P. Fenaux, U. Platzbecker, G. Mufti, G. Garcia-Manero +35 more
2018Blood62 citations
Semantic Scholar
Clinical Impact of Polymerase Chain Reaction–Based Aspergillus and Azole Resistance Detection in Invasive Aspergillosis: A Prospective Multicenter Study
Sammy Huygens, A. Dunbar, J. Buil, C. Klaassen +30 more
2023Clinical Infectious Diseases56 citations Open access
Semantic Scholar
Allogeneic Stem Cell Transplantation for Patients Age ≥ 70 Years with Myelodysplastic Syndrome: A Retrospective Study of the MDS Subcommittee of the Chronic Malignancies Working Party of the EBMT.
S. Heidenreich, D. Ziagkos, L. D. de Wreede, A. van Biezen +22 more
2017Biology of Blood and Marrow Transplantation55 citations Open access
Semantic Scholar
Empiric vs Preemptive Antifungal Strategy in High-Risk Neutropenic Patients on Fluconazole Prophylaxis: A Randomized Trial of the European Organization for Research and Treatment of Cancer
J. Maertens, T. Lodewyck, J. Donnelly, S. Chantepie +27 more
2022Clinical Infectious Diseases50 citations Open access
Semantic Scholar
Impact of unresolved neutropenia in patients with neutropenia and invasive aspergillosis: a post hoc analysis of the SECURE trial
D. Kontoyiannis, D. Selleslag, K. Mullane, O. Cornely +6 more
2018Journal of Antimicrobial Chemotherapy45 citations Open access
Semantic Scholar
A large observational study of patients with primary immune thrombocytopenia receiving romiplostim in European clinical practice
M. Steurer, P. Quittet, H. Papadaki, D. Selleslag +8 more
2017European Journal of Haematology41 citations Open access
Semantic Scholar
Recombinant zoster vaccine significantly reduces the impact on quality of life caused by herpes zoster in adult autologous hematopoietic stem cell transplant recipients: a randomized placebo-controlled trial (ZOE-HSCT).
D. Curran, S. Matthews, S. Rowley, Jo-Anne H. Young +22 more
2019Biology of Blood and Marrow Transplantation39 citations Open access
Semantic Scholar
Design of the randomized, Phase III, QUAZAR AML Maintenance trial of CC-486 (oral azacitidine) maintenance therapy in acute myeloid leukemia
G. Roboz, P. Montesinos, D. Selleslag, A. Wei +12 more
2016Future Oncology39 citations Open access
Semantic Scholar
Haploidentical transplant in patients with myelodysplastic syndrome.
M. Robin, R. Porcher, F. Ciceri, M. T. van Lint +21 more
2017Blood Advances37 citations Open access
Semantic Scholar
A randomised, placebo-controlled phase 3 study to evaluate the efficacy and safety of ASP0113, a DNA-based CMV vaccine, in seropositive allogeneic haematopoietic cell transplant recipients
P. Ljungman, A. Bermúdez, A. Logan, M. Kharfan-Dabaja +18 more
2021EClinicalMedicine34 citations Open access
Semantic Scholar
Postremission cytopenia management in patients with acute myeloid leukemia treated with venetoclax and azacitidine in VIALE‐A
K. Pratz, C. Dinardo, D. Selleslag, Jun Yu Li +15 more
2022American journal of hematology/oncology32 citations
Semantic Scholar
The eGVHD App has the potential to improve the accuracy of graft-versus-host disease assessment: a multicenter randomized controlled trial
H. Schoemans, K. Goris, R. Van Durm, S. Fieuws +15 more
2018Haematologica30 citations Open access
Semantic Scholar
Infusion of bone marrow derived multipotent mesenchymal stromal cells for the treatment of steroid-refractory acute graft-versus-host disease: a multicenter prospective study
S. Servais, F. Baron, C. Lechanteur, L. Seidel +11 more
2018OncoTarget26 citations Open access
Semantic Scholar
Use of chimerism analysis after allogeneic stem cell transplantation: Belgian guidelines and review of the current literature
Anke Delie, A. Verlinden, K. Beel, D. Deeren +12 more
2020Acta Clinica Belgica25 citations Open access
Semantic Scholar
Immunological monitoring after allogeneic stem cell transplantation: T-SPOT.CMV and QuantiFERON-CMV, are they the same?
R. Callens, Sofie Colman, Anke Delie, A. Schauwvlieghe +5 more
2023Transplantation and Cellular Therapy24 citations Open access
Semantic Scholar
ATIR101 administered after T-cell-depleted haploidentical HSCT reduces NRM and improves overall survival in acute leukemia
D. Roy, I. Walker, J. Maertens, P. Lewalle +11 more
2020Leukemia22 citations Open access
Semantic Scholar
Clofarabine added to intensive treatment in adult patients with newly diagnosed ALL: the HOVON-100 trial
A. Rijneveld, B. van der Holt, O. de Weerdt, B. Biemond +31 more
2021Blood Advances21 citations Open access
Semantic Scholar
Clinical outcomes in patients with Philadelphia chromosome-positive leukemia treated with ponatinib in routine clinical practice—data from a Belgian registry
T. Devos, V. Havelange, K. Theunissen, S. Meers +17 more
2021Annals of Hematology19 citations Open access
Semantic Scholar
A phase 2a randomized clinical trial of intravenous vedolizumab for the treatment of steroid-refractory intestinal acute graft-versus-host disease
Y. Fløisand, M. Schroeder, P. Chevallier, D. Selleslag +10 more
2021Bone Marrow Transplantation19 citations Open access
Semantic Scholar
Multipotent mesenchymal stromal cells as treatment for poor graft function after allogeneic hematopoietic cell transplantation: A multicenter prospective analysis
S. Servais, F. Baron, C. Lechanteur, L. Seidel +13 more
2023Frontiers in Immunology18 citations Open access
Semantic Scholar
Effectiveness and Safety of Romiplostim Among Patients with Newly Diagnosed, Persistent and Chronic Immune Thrombocytopenia in European Clinical Practice
Sara J. Snell Taylor, C. Nielson, A. Breskin, Bradley C. Saul +15 more
2021Advances in Therapy18 citations Open access
Semantic Scholar
Management of adverse events in patients with acute myeloid leukemia in remission receiving oral azacitidine: experience from the phase 3 randomized QUAZAR AML-001 trial
F. Ravandi, G. Roboz, A. Wei, H. Döhner +18 more
2021Journal of Hematology & Oncology18 citations Open access
Semantic Scholar
Clinical implications of measurable residual disease in AML: Review of current evidence.
I. Moors, K. Vandepoele, J. Philippé, D. Deeren +5 more
2019Critical reviews in oncology/hematology17 citations
Semantic Scholar
Sequential administration of low dose 5-azacytidine (AZA) and donor lymphocyte infusion (DLI) for patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) in relapse after allogeneic stem cell transplantation (SCT): a prospective study from the Belgian Hematology Society (BHS)
X. Poiré, C. Graux, Aurélie Ory, J. Herman +10 more
2021Bone Marrow Transplantation16 citations Open access
Semantic Scholar
Long‐term survival with oral azacitidine for patients with acute myeloid leukemia in first remission after chemotherapy: Updated results from the randomized, placebo‐controlled, phase 3 QUAZAR AML‐001 trial
A. Wei, H. Döhner, H. Sayar, F. Ravandi +14 more
2023American journal of hematology/oncology15 citations Open access
Semantic Scholar
A Phase 3, Randomized, Double-Blind, Comparator-Controlled Study to Evaluate Safety, Tolerability, and Immunogenicity of V114, a 15-Valent Pneumococcal Conjugate Vaccine, in Allogeneic Hematopoietic Cell Transplant Recipients (PNEU-STEM)
M. Wilck, O. Cornely, C. Cordonnier, J. Vélez +16 more
2023Clinical Infectious Diseases15 citations Open access
Semantic Scholar
Cytopenia Management in Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With Venetoclax Plus Azacitidine in the VIALE-A Study
K. Pratz, C. Dinardo, D. Selleslag, Junmin Li +18 more
202015 citations
Semantic Scholar
Phase II study of pevonedistat (P) + azacitidine (A) versus A in patients (pts) with higher-risk myelodysplastic syndromes (MDS)/chronic myelomonocytic leukemia (CMML), or low-blast acute myelogenous leukemia (LB AML) (NCT02610777).
L. Adès, J. Watts, A. Radinoff, M. Arnán +12 more
202015 citations
Semantic Scholar
Updated recommendations on the use of ruxolitinib for the treatment of myelofibrosis
T. Devos, D. Selleslag, N. Granacher, V. Havelange +1 more
2021Hematology14 citations Open access
Semantic Scholar
Oral azacitidine preserves favorable level of fatigue and health-related quality of life for patients with acute myeloid leukemia in remission: results from the phase III, placebo-controlled QUAZAR AML-001 trial
G. Roboz, H. Döhner, C. Pocock, H. Dombret +18 more
2021Haematologica13 citations Open access
Semantic Scholar
Safety and efficacy of self‐administered romiplostim in patients with immune thrombocytopenia: Results of an integrated database of five clinical trials
D. Kuter, D. Arnold, F. Rodeghiero, A. Janssens +6 more
2020American journal of hematology/oncology13 citations Open access
Semantic Scholar
Management of immune thrombocytopenia in multiple sclerosis patients treated with alemtuzumab: a Belgian consensus
C. Lambert, B. Dubois, D. Dive, A. Lysandropoulos +5 more
2018Acta Neurologica Belgica13 citations Open access
Semantic Scholar
Efficacy of ruxolitinib in B‐lymphoblastic leukaemia with the PCM1–JAK2 fusion gene
Y. Wouters, Louis Nevejan, Annelies Louwagie, H. Devos +3 more
2021British Journal of Haematology12 citations
Semantic Scholar
Mediastinal Myeloid Sarcoma with TP53 Mutation Preceding Acute Myeloid Leukemia with a PICALM-MLLT10 Fusion Gene
L. Naesens, H. Devos, F. Nollet, L. Michaux +1 more
2018Acta Haematologica12 citations Open access
Semantic Scholar
Treatment outcomes in patients with proven/probable vs possible invasive mould disease in a phase III trial comparing isavuconazole vs voriconazole
J. Maertens, D. Selleslag, W. Heinz, M. Saulay +9 more
2018Mycoses (Berlin)12 citations Open access
Semantic Scholar
Heterogeneity and viral replication fitness of HSV-1 clinical isolates with mutations in the thymidine kinase and DNA polymerase.
Hanna Helena Schalkwijk, Sarah Gillemot, M. Reynders, D. Selleslag +2 more
2022Journal of Antimicrobial Chemotherapy11 citations Open access
Semantic Scholar
Infectious diarrhea after allogeneic hematopoietic cell transplantation assessed by a multiplex polymerase chain reaction assay.
J. V. Van Praet, Andreas Huysman, Eline De Knijf, S. De Buyser +6 more
2022International Journal of Infectious Diseases10 citations Open access
Semantic Scholar
A Belgian consensus protocol for autologous hematopoietic stem cell transplantation in multiple sclerosis
G. Laureys, B. Willekens, L. Vanopdenbosch, O. Deryck +15 more
2018Acta Neurologica Belgica10 citations Open access
Semantic Scholar
Outcomes of haploidentical stem cell transplantation for chronic lymphocytic leukemia: a retrospective study on behalf of the chronic malignancies working party of the EBMT
G. V. van Gorkom, M. van Gelder, D. Eikema, Henric-Jan Blok +20 more
2018Bone Marrow Transplantation9 citations Open access
Semantic Scholar
Clinical characteristics and outcomes according to age in lenalidomide-treated patients with RBC transfusion-dependent lower-risk MDS and del(5q)
P. Fenaux, A. Giagounidis, D. Selleslag, O. Beyne-Rauzy +14 more
2017Journal of Hematology & Oncology9 citations Open access
Semantic Scholar
Venetoclax and azacitidine in untreated patients with therapy-related acute myeloid leukemia, antecedent myelodysplastic syndromes or chronic myelomonocytic leukemia
V. Pullarkat, K. Pratz, H. Döhner, Christian Récher +16 more
2025Blood Cancer Journal8 citations Open access
Semantic Scholar
CC-486 Improves Overall Survival (OS) and Relapse-Free Survival (RFS) for Patients with Acute Myeloid Leukemia (AML) in First Remission after Intensive Chemotherapy (IC), Regardless of Amount of Consolidation Received: Results from the Phase III QUAZAR AML-001 Maintenance Trial
A. Wei, G. Roboz, H. Dombret, H. Döhner +11 more
20208 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

J. Maertens×13
Invite
J. Maertens — researcher profile on SciRah
H. Döhner×8
Invite
H. Döhner — researcher profile on SciRah
B. Skikne×8
Invite
B. Skikne — researcher profile on SciRah
T. Kerre×8
Invite
T. Kerre — researcher profile on SciRah

×7

Invite

A. Wei — researcher profile on SciRah

Invite

H. Dombret — researcher profile on SciRah

Invite

F. Ravandi — researcher profile on SciRah

Invite

C. Beach — researcher profile on SciRah

Invite

G. Roboz — researcher profile on SciRah

P. Montesinos×6

Invite

P. Montesinos — researcher profile on SciRah

Invite

C. Graux — researcher profile on SciRah

Invite

F. Baron — researcher profile on SciRah